Screening for mutations in Tp53 tumor suppressor gene using DGGe and sequencing
iskanje mutacij v tumorskem supresorskem genu Tp53 z uporabo DGGEin sekveniranja
Keywords:cancer screening, mutations, Tp53 gene
Mutacije v genu Tp53 so dokazane pri več kot 50 % malignih bolezni. Pri številnih malignih bolezni je vloga mutacij v tem genu neposredno povezana z nastankom raka. Namen našega prispevka je posredovati informacijo o metodoloških pristopih, s katerimi določamo mutacije v genu Tp53 na Oddelku za molekularno diagnostiko Onkološkega inštituta Ljubljana.
Mutations in the T53 gene have been detected in more than 50% of different malignancies. The development of many of these diseases is directly associated with the mutations in the Tp53 gene. The aim of this article is to provide information about new methods that have been introduced into our Department of Molecular Diagnostics at the Institute of Oncology Ljubljana for scanning mutations in the Tp53 gene.
How to Cite
The journal is published under the terms of the Creative Commons Attribution License CC-BY 4.0. The authors retain the copyright to their work without any restrictions whatsoever.
This journal is an open-access journal, meaning that all of its contents are freely accessible without any charge to the user or their institution. In accordance with the Budapest Open Access Initiative (BOAI) definition of open access, users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking for prior permission from the publisher or the author, provided the authors and the journal are appropriately credited.